Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Peripartum cardiomyopathy
Alan Berger,
Daniel J. Garry
Medicine - Cardiology Division
Cellular Mechanisms of Cancer
Lillehei Heart Institute
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Peripartum cardiomyopathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Peripartum Cardiomyopathy
100%
Risk Factors
66%
United States
33%
Heart Failure
33%
Pregnancy Disorders
33%
Etiology
33%
Treatment Options
33%
Hypertension
33%
Haiti
33%
Standard of Care
33%
Clinical Presentation
33%
Cardiac Transplantation
33%
During Pregnancy
33%
Inotropic Therapy
33%
Double-blinded Study
33%
South Africa
33%
Clinical Benefit
33%
Implantable Devices
33%
Left Ventricular Ejection Fraction
33%
Maternal Mortality
33%
Cardiogenic Shock
33%
Emerging Therapies
33%
Differential Diagnosis
33%
Life-limiting Conditions
33%
Oxygenation
33%
Idiopathic Dilated Cardiomyopathy
33%
Acute Management
33%
Live Birth
33%
Vasodilator Therapy
33%
Cocaine Use
33%
Defibrillator
33%
Maternal Age
33%
Pharmacological Treatment
33%
Hemodynamic Support
33%
Cardiac Resynchronization Therapy
33%
Chronic Management
33%
Bromocriptine
33%
Risk Incidence
33%
Differential Treatment
33%
Multiparity
33%
Mortality Prognosis
33%
Multiple Embryos
33%
Device Pose
33%
Tocolytic Therapy
33%
Nursing and Health Professions
Peripartum Cardiomyopathy
100%
Medical Device
33%
Health Care Quality
33%
Live Birth
33%
Oxygenation
33%
Defibrillator
33%
Congestive Cardiomyopathy
33%
Drug Therapy
33%
South Africa
33%
Heart Transplantation
33%
Congestive Heart Failure
33%
Heart Left Ventricle Ejection Fraction
33%
Maternal Mortality
33%
Maternal Age
33%
Hemodynamic Support
33%
Differential Diagnosis
33%
Cardiogenic Shock
33%
Cardiac Resynchronization Therapy
33%
Bromocriptine
33%
Diseases
33%
Medicine and Dentistry
Peripartum Cardiomyopathy
100%
Drug Therapy
33%
Medical Device
33%
Heart Transplantation
33%
Dilated Cardiomyopathy
33%
Heart Left Ventricle Ejection Fraction
33%
Congestive Heart Failure
33%
Differential Diagnosis
33%
Inotropism
33%
Cardiogenic Shock
33%
Hemodynamic Support
33%
Maternal Mortality
33%
Maternal Age
33%
Cardiac Resynchronization Therapy
33%
Bromocriptine
33%
Defibrillator
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Peripartum Cardiomyopathy
100%
Congestive Cardiomyopathy
33%
Maternal Mortality
33%
Congestive Heart Failure
33%
Cardiogenic Shock
33%
Bromocriptine
33%
Diseases
33%